S&P TSX Capped Composite...

US Dollar vs CAD

Trade smarter, not harder: Unleash your inner pro with our toolkit and live discussions.

Get Started

DMAC DiaMedica Therapeutics Inc

3.25

-0.22 (-6.34%)

Last Updated: 14:58:42

Delayed by 15 minutes

Form 3 - Initial statement of beneficial ownership of securities

DiaMedica Therapeutics (NASDAQ:DMAC)
Historical Stock Chart
From Apr 2024 to May 2024

Click Here for more DiaMedica Therapeutics Charts.

DiaMedica Therapeutics (NASDAQ:DMAC)
Historical Stock Chart
From May 2023 to May 2024

Click Here for more DiaMedica Therapeutics Charts.

DiaMedica Therapeutics Inc News

Form 10-Q - Quarterly report [Sections 13 or 15(d)]
Wednesday 8 May 2024 (24 hours ago) • Edgar (US Regulatory)

Form 8-K - Current report
Wednesday 8 May 2024 (24 hours ago) • Edgar (US Regulatory)

DiaMedica Therapeutics Provides a Business Update and Announces First Quarter 2024 Financial Results
Wednesday 8 May 2024 (24 hours ago) • Business Wire

DiaMedica Therapeutics to Report First Quarter 2024 Financial Results and Provide a Business Update May 9, 2024
Thursday 2 May 2024 (1 week ago) • Business Wire

DiaMedica Therapeutics Announces First Patient Dosed in Relaunch of its Pivotal Phase 2/3 ReMEDy2 Trial of DM199 for the Treatment of Acute Ischemic Stroke
Wednesday 17 April 2024 (3 weeks ago) • Business Wire

DiaMedica Therapeutics Provides a Business Update and Announces Full Year 2023 Financial Results
Tuesday 19 March 2024 (2 months ago) • Business Wire

DiaMedica Therapeutics Announces Poster Presentation at International Stroke Conference
Monday 29 January 2024 (3 months ago) • Business Wire

Form 4 - Statement of changes in beneficial ownership of securities
Tuesday 23 January 2024 (4 months ago) • Edgar (US Regulatory)

Form 3 - Initial statement of beneficial ownership of securities
Tuesday 23 January 2024 (4 months ago) • Edgar (US Regulatory)

DiaMedica Therapeutics Appoints Dr. Lorianne Masuoka as Chief Medical Officer
Monday 22 January 2024 (4 months ago) • Business Wire

Form 4 - Statement of changes in beneficial ownership of securities
Tuesday 2 January 2024 (4 months ago) • Edgar (US Regulatory)

Form 4 - Statement of changes in beneficial ownership of securities
Tuesday 2 January 2024 (4 months ago) • Edgar (US Regulatory)

More DiaMedica Therapeutics Inc News Articles

Brookmount Explorations (PK)

Ronn Motor (PK)

Kraig Biocraft Laborator... (QB)

Innovation Pharmaceuticals (CE)

Globestar Therapeutics (PK)

Ecare Solutions (PK)

MicroCloud Hologram

NaturalShrimp (QB)

Kona Gold Beverage (PK)

Indoor Harvest (PK)

1812 Brewing (PK)

Auto Parts 4Less (PK)

Clean Vision (QB)

Delayed Upgrade Clock

Support: +44 (0) 203 8794 460 | support@advfn.com

By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions